Subscribe to this journal
Advanced Search
 array:22 [
  "pii" => "S2254887424001371"
  "issn" => "22548874"
  "doi" => "10.1016/j.rceng.2024.10.007"
  "estado" => "S5"
  "fechaPublicacion" => "2024-10-29"
  "aid" => "2245"
  "copyright" => "Elsevier Ltd. All rights reserved"
  "copyrightAnyo" => "2024"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:16 [
    "pii" => "S2254887424001413"
    "issn" => "22548874"
    "doi" => "10.1016/j.rceng.2024.10.011"
    "estado" => "S5"
    "fechaPublicacion" => "2024-10-31"
    "aid" => "2249"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "Circadian pattern of blood pressure in patients with stable COPD"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Patrón circadiano de presión arterial en pacientes con EPOC estable"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. Díez-Manglano, J.A. Díaz-Peromingo, R. Boixeda-Viu"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "J."
              "apellidos" => "Díez-Manglano"
            ]
            1 => array:2 [
              "nombre" => "J.A."
              "apellidos" => "Díaz-Peromingo"
            ]
            2 => array:2 [
              "nombre" => "R."
              "apellidos" => "Boixeda-Viu"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001413?idApp=WRCEE"
    "url" => "/22548874/unassign/S2254887424001413/v1_202410310625/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "S2254887424001103"
    "issn" => "22548874"
    "doi" => "10.1016/j.rceng.2024.08.001"
    "estado" => "S200"
    "fechaPublicacion" => "2024-08-28"
    "aid" => "2233"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Soluble receptor for advanced glycation end-products positively correlated to kidney injury with coronary heart disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El receptor soluble para productos finales de glicaci&#243;n avanzada se correlacion&#243; positivamente con la lesi&#243;n renal con la enfermedad coronaria"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1825
              "Ancho" => 3341
              "Tamanyo" => 319191
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0015"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Correlation analysis between sRAGE and uACR in CHD patients &#40;A&#41;&#44; and ROC analysis of sRAGE&#44; UMA&#44; eGFR&#44; SCr&#44; UCr&#44; Albumin and BUN with uACR&#160;&#8805;&#160;30&#160;mg&#47;g in CHD patients &#40;B&#41;&#46;</p> <p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Each dot represents an individual patient&#46; BUN&#58; blood urea nitrogen&#59; CHD&#58; coronary heart disease&#59; eGFR&#58; estimated Glomerular Filtration Rate&#59; ROC&#58; receiver operating characteristic&#59; SCr&#58; serum creatinine&#59; sRAGE&#58; soluble receptor for advanced glycation end products&#59; uACR&#58; urinary albumin to creatinine ratio&#59; UCr&#58; urine creatinine&#59; UMA&#58; urine microalbumin&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lu Chen, Xiang-Jun Zeng, Xin-Ying Guo, Jian Liu, Feng-He Du, Cai-Xia Guo"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Lu"
              "apellidos" => "Chen"
            ]
            1 => array:2 [
              "nombre" => "Xiang-Jun"
              "apellidos" => "Zeng"
            ]
            2 => array:2 [
              "nombre" => "Xin-Ying"
              "apellidos" => "Guo"
            ]
            3 => array:2 [
              "nombre" => "Jian"
              "apellidos" => "Liu"
            ]
            4 => array:2 [
              "nombre" => "Feng-He"
              "apellidos" => "Du"
            ]
            5 => array:2 [
              "nombre" => "Cai-Xia"
              "apellidos" => "Guo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0014256524001498"
        "doi" => "10.1016/j.rce.2024.06.016"
        "estado" => "S200"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256524001498?idApp=WRCEE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001103?idApp=WRCEE"
    "url" => "/22548874/unassign/S2254887424001103/v1_202408280421/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
    "titulo" => "2024 Spanish Society of Internal Medicine &#40;SEMI&#41; recommendations for the management of cancer-associated venous thrombosis"
    "tieneTextoCompleto" => 0
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Aurora Villalobos, Reina Valle, Javier Pag&#225;n-Escribano, Mar&#237;a Ortiz, Pablo Demelo-Rodr&#237;guez, Carme Font"
        "autores" => array:6 [
          0 => array:3 [
            "nombre" => "Aurora"
            "apellidos" => "Villalobos"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Reina"
            "apellidos" => "Valle"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Javier"
            "apellidos" => "Pag&#225;n-Escribano"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Mar&#237;a"
            "apellidos" => "Ortiz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Pablo"
            "apellidos" => "Demelo-Rodr&#237;guez"
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">f</span>"
                "identificador" => "aff0030"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">g</span>"
                "identificador" => "aff0035"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">h</span>"
                "identificador" => "aff0040"
              ]
            ]
          ]
          5 => array:4 [
            "nombre" => "Carme"
            "apellidos" => "Font"
            "email" => array:2 [
              0 => "Carme.fontpuig@gmail.com"
              1 => "CFONT@clinic.cat"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">i</span>"
                "identificador" => "aff0045"
              ]
              1 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:9 [
          0 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital Universitario Regional de M&#225;laga"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital Sierrallana&#44; Torrelavega"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidad de Enfermedad Tromboemb&#243;lica Venosa&#44; Medicina Interna&#44; Hospital General Universitario Jos&#233; Mar&#237;a Morales Meseguer"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Centro Regional de Hemodonaci&#243;n&#44; Servicio Murciano de Salud"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital Clinic de Barcelona"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
          5 => array:3 [
            "entidad" => "Unidad de Enfermedad Tromboemb&#243;lica Venosa&#44; Medicina Interna&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n"
            "etiqueta" => "f"
            "identificador" => "aff0030"
          ]
          6 => array:3 [
            "entidad" => "Instituto de Investigaci&#243;n Sanitaria Gregorio Mara&#241;&#243;n"
            "etiqueta" => "g"
            "identificador" => "aff0035"
          ]
          7 => array:3 [
            "entidad" => "Facultad de Medicina&#44; Universidad Complutense de Madrid"
            "etiqueta" => "h"
            "identificador" => "aff0040"
          ]
          8 => array:3 [
            "entidad" => "Servicio de Oncolog&#237;a M&#233;dica&#44; Hospital Clinic de Barcelona"
            "etiqueta" => "i"
            "identificador" => "aff0045"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Recomendaciones 2024 de la Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41; para el manejo de la trombosis venosa asociada al c&#225;ncer"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2024-04-24"
    "fechaAceptado" => "2024-09-02"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1899800"
          "palabras" => array:3 [
            0 => "cancer-associated thrombosis"
            1 => "paraneoplastic thrombosis"
            2 => "consensus recommendations for clinical practice"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1899799"
          "palabras" => array:3 [
            0 => "Trombosis asociada al c&#225;ncer"
            1 => "Trombosis paraneopl&#225;sica"
            2 => "Recomendaciones de consenso para la pr&#225;ctica cl&#237;nica"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Venous thromboembolic disease &#40;VTD&#41; is a common complication associated to greater mortality in patients with cancer&#46; Its etiology is multifactorial and depends on the characteristics and co-morbidities of the patient&#44; the tumor type and extension&#44; and the oncological treatment&#46; The management of VTD is more complex in patients with cancer due to an increased risk of recurrence and major bleeding complications during anticoagulation compared to the general non-oncological population&#46; The above differences have led to the development of specific clinical trials to assess the efficacy and safety of anticoagulant therapy in patients with cancer&#46; The present clinical guidelines are intended to provide general recommendations on the management of cancer-associated VTD according to updated according to the most recent scientific evidence&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">La enfermedad tromboemb&#243;lica venosa &#40;ETV&#41; es una complicaci&#243;n frecuente y que se asocia a mayor mortalidad en los pacientes con c&#225;ncer&#46; Su etiolog&#237;a es multifactorial y depende de las caracter&#237;sticas y comorbilidades del paciente&#44; del tipo y extensi&#243;n del tumor y del tratamiento oncol&#243;gico&#46; El manejo de la ETV en los pacientes con c&#225;ncer es m&#225;s complejo debido a un mayor riesgo de recurrencia a pesar del tratamiento anticoagulante y de complicaciones hemorr&#225;gicas comparado con la poblaci&#243;n general&#46; Estas diferencias han llevado al desarrollo de ensayos cl&#237;nicos espec&#237;ficos para evaluar la eficacia y seguridad del tratamiento anticoagulante en la poblaci&#243;n oncol&#243;gica&#46; Estas gu&#237;as pretenden dar recomendaciones generales sobre el manejo de la ETV asociada al c&#225;ncer seg&#250;n la evidencia cient&#237;fica m&#225;s reciente&#46;</p></span>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/22548874/unassign/S2254887424001371/v1_202410291020/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/22548874/unassign/S2254887424001371/v1_202410291020/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001371?idApp=WRCEE"
]
Share
Articles in press 2024 Spanish Society of Internal Medicine (SEMI) recommendations for the management...
Journal Information
Export reference
Share
Share
Print
Download PDF
More article options
Statistics
Special article
DOI: 10.1016/j.rceng.2024.10.007
Pre-proof, online 29 October 2024
2024 Spanish Society of Internal Medicine (SEMI) recommendations for the management of cancer-associated venous thrombosis
Recomendaciones 2024 de la Sociedad Española de Medicina Interna (SEMI) para el manejo de la trombosis venosa asociada al cáncer
Download PDF
Aurora Villalobosa, Reina Valleb, Javier Pagán-Escribanoc,d, María Ortize, Pablo Demelo-Rodríguezf,g,h, Carme Fonti,
Corresponding author
Carme.fontpuig@gmail.com
CFONT@clinic.cat

Corresponding author.
a Servicio de Medicina Interna, Hospital Universitario Regional de Málaga
b Servicio de Medicina Interna, Hospital Sierrallana, Torrelavega
c Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario José María Morales Meseguer
d Centro Regional de Hemodonación, Servicio Murciano de Salud
e Servicio de Medicina Interna, Hospital Clinic de Barcelona
f Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón
g Instituto de Investigación Sanitaria Gregorio Marañón
h Facultad de Medicina, Universidad Complutense de Madrid
i Servicio de Oncología Médica, Hospital Clinic de Barcelona
Ver más
Article information
Abstract
Download PDF
Statistics
Abstract

Venous thromboembolic disease (VTD) is a common complication associated to greater mortality in patients with cancer. Its etiology is multifactorial and depends on the characteristics and co-morbidities of the patient, the tumor type and extension, and the oncological treatment. The management of VTD is more complex in patients with cancer due to an increased risk of recurrence and major bleeding complications during anticoagulation compared to the general non-oncological population. The above differences have led to the development of specific clinical trials to assess the efficacy and safety of anticoagulant therapy in patients with cancer. The present clinical guidelines are intended to provide general recommendations on the management of cancer-associated VTD according to updated according to the most recent scientific evidence.

Keywords:
cancer-associated thrombosis
paraneoplastic thrombosis
consensus recommendations for clinical practice
Resumen

La enfermedad tromboembólica venosa (ETV) es una complicación frecuente y que se asocia a mayor mortalidad en los pacientes con cáncer. Su etiología es multifactorial y depende de las características y comorbilidades del paciente, del tipo y extensión del tumor y del tratamiento oncológico. El manejo de la ETV en los pacientes con cáncer es más complejo debido a un mayor riesgo de recurrencia a pesar del tratamiento anticoagulante y de complicaciones hemorrágicas comparado con la población general. Estas diferencias han llevado al desarrollo de ensayos clínicos específicos para evaluar la eficacia y seguridad del tratamiento anticoagulante en la población oncológica. Estas guías pretenden dar recomendaciones generales sobre el manejo de la ETV asociada al cáncer según la evidencia científica más reciente.

Palabras clave:
Trombosis asociada al cáncer
Trombosis paraneoplásica
Recomendaciones de consenso para la práctica clínica

Article

These are the options to access the full texts of the publication Revista Clínica Española (English Edition)
Member of the society
Subscriber
Subscribe
Contact
Member
Si es usted socio de FESEMI siga los siguientes pasos:

Diríjase desde aquí a la web de la >>>FESEMI<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.

Una vez autentificado, en la misma web de FESEMI, en el menú superior, elija la opción deseada.

>>>FESEMI<<<

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Clínica Española (English Edition)

More information
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
atencionalcliente@elsevier.com

Subscribe to our newsletter

Highlighted articles
Publish in
Revista Clínica Española
Free access articles
The value of multi-modal ultrasound in the assessment of...
Rev Clin Esp. 2024;224:437-44
Adverse cardiovascular, obstetric and perinatal events...
Rev Clin Esp. 2024;224:337-45
How to detect non-institutionalized older patients at risk...
Rev Clin Esp. 2024;224:217-24
Revista Clínica Española (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Revista Clínica Española (English Edition)
Article options
Tools